Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04599803 · ClinicalTrials.gov registry record · NA
Baseline Sleep Apnea Study #2
A NA study, sponsored by Verily Life Sciences.
- Completed
- Registry status
- NA
- Development phase
- 187
- Enrollment target
NCT04599803: Completed NA study, sponsored by Verily Life Sciences.
NCT04599803 is a NA study that has completed, run by Verily Life Sciences. The registered enrollment target is 187 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04599803, a NA study, has completed, sponsored by Verily Life Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 187 participants
- Enrollment target
Study Summary
This is a single group, unblinded, prospective clinical study. This study seeks to understand patient diagnostic and treatment journey and positive airway pressure (PAP) therapy compliance for Verily Sleep Apnea (VSA) program/app users. Participants will enroll remotely and may undergo a home sleep test (HST). Upon confirmation of obstructive sleep apnea (OSA) and prescription of PAP therapy, the participant will begin using the VSA app to supplement PAP treatment. After 90 days of active participation, the participant will be given instructions for follow-up care, as indicated.
Primary Outcome
Time (number of days) from when participant is told they may have OSA to when they receive HST prescription
Interventions
- DEVICE Verily Sleep Apnea (VSA) Program/App
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 187 participants |
| Start Date | 2020-07-08 |
| Est. Completion | 2021-03-30 |
| Phase | NA |
What the finished NCT04599803 record still lists
NCT04599803 is an interventional study that assigns participants to a tested intervention. The registered 187 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower).
The record links to 0 conditions, and to 1 intervention - of which Verily Sleep Apnea (VSA) Program/App is the first listed.
NCT04599803 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04599803 about?
NCT04599803 is a clinical study titled "Baseline Sleep Apnea Study #2". This is a single group, unblinded, prospective clinical study. This study seeks to understand patient diagnostic and treatment journey and positive airway pressure (PAP) therapy compliance for Verily Sleep Apnea (VSA) program/app users. Participants will enroll remotely and may undergo a home sleep ...
What is the current status of trial NCT04599803?
This trial is currently completed. It is a NA study. The enrollment target is 187 participants. The study started on 2020-07-08. Estimated completion is 2021-03-30.
What interventions are being tested in trial NCT04599803?
The interventions under investigation include: Verily Sleep Apnea (VSA) Program/App (DEVICE).
Who is sponsoring clinical trial NCT04599803?
This trial is sponsored by Verily Life Sciences, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04599803's enrollment target sits among peer trials
187 579th of 2000 higher than 1,422 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06153251 · 187 participants · Phase 1
A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma
- NCT06254898 · 187 participants · NA
Use of Incentives for Stressful Medical Procedures
- NCT07062237 · 187 participants · NA
A Randomized Clinical Trial Comparing Embryo Euploidy Rates Following Ultrashort Versus Standard Abstinence
- NCT07217574 · 187 participants
Program in Oncology for Tribal Health Systems.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI